These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3180616)

  • 41. Myasthenia gravis accompanied by Graves' disease, thyrotoxic hypokalemic periodic paralysis and thymic hyperplasia.
    Huang K; Luo YB; Yang H; Yang XS; Li J
    Neurol India; 2016; 64(4):783-5. PubMed ID: 27381127
    [No Abstract]   [Full Text] [Related]  

  • 42. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.
    Kim WB; Han SM; Kim TY; Nam-Goong IS; Gong G; Lee HK; Hong SJ; Shong YK
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):719-25. PubMed ID: 15163336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia.
    Tsuda E; Imai T; Matsumura A; Hisahara S; Nonaka M; Shiraishi H; Motomura M; Shimohama S
    Intern Med; 2008; 47(5):445-7. PubMed ID: 18310980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thymic hyperplasia in a patient with Graves' disease].
    García E; García-Hierro V; Pilar Alvarez M; de la Maza L; Santos E; Pi J; Castillo L; Ruiz E
    Endocrinol Nutr; 2009 Feb; 56(2):92-5. PubMed ID: 19627717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [An enlarged thymus associated with Graves' disease].
    Wouters MPAM; Wolffenbuttel BHR; Links TP; Groen HJM; Wouters RSME
    Ned Tijdschr Geneeskd; 2018 Jul; 162():. PubMed ID: 30182634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [F-qi-FDG PET of the thyroid gland in Graves' disease].
    Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
    Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin receptor scintigraphy using (99m)Tc-EDDA/HYNIC-TOC in graves' disease.
    Gabriel M; Decristoforo C; Moncayo R
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1267. PubMed ID: 12418470
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thymic hyperplasia and Graves' disease: a non-fortuitous association. case report and review of literature].
    Desforges-Bullet V; Petit-Aubert G; Collet-Gaudillat C; Cerceau R; Fraleu-Louer B; Meckenstock R; Greder A; Cordoliani Y; Beressi JP
    Ann Endocrinol (Paris); 2011 Sep; 72(4):304-309. PubMed ID: 21777902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment.
    Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
    Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymic enlargement in two cases of Graves' disease.
    Nakamura S
    Intern Med; 2012; 51(6):673-4. PubMed ID: 22449686
    [No Abstract]   [Full Text] [Related]  

  • 51. Graves' disease presented as painful goiter.
    Chao CS; Lin SY; Sheu WH
    Horm Res; 2002; 57(1-2):53-6. PubMed ID: 12006721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy dose calculation in Graves' disease using early I-123 uptake measurements.
    Vemulakonda US; Atkins FB; Ziessman HA
    Clin Nucl Med; 1996 Feb; 21(2):102-5. PubMed ID: 8697676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease].
    Li J; Zhang J; Bai Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):170-4. PubMed ID: 7805159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thymic uptake of gallium in a patient with unsuspected hyperthyroidism.
    Mele F; Forman B; Caride VJ
    AJR Am J Roentgenol; 1996 Feb; 166(2):450-1. PubMed ID: 8553965
    [No Abstract]   [Full Text] [Related]  

  • 55. Toxic Graves' disease with thyroid hemiagenesis: diagnosis using thyroid-stimulating immunoglobulin measurements.
    Shechner C; Kraiem Z; Zuckerman E; Dickstein G
    Thyroid; 1992; 2(2):133-5. PubMed ID: 1356055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
    Yunusa GH; Kotze T; Brink A
    Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.
    Dimai HP; Ramschak-Schwarzer S; Lax S; Lipp RW; Leb G
    J Endocrinol Invest; 1999 Mar; 22(3):215-9. PubMed ID: 10219891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased bone alkaline phosphatase and isolated subcortical bone uptake of technetium-99m hydroxymethylene diphosphonate in the lower extremities in a patient with Graves' disease: a distinctly unusual variant of Graves' acropachy.
    Ogrin C
    Thyroid; 2008 Nov; 18(11):1227-9. PubMed ID: 19014329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prediction of remission in Graves' disease after thionamide therapy by technetium-99m early uptake].
    Misaki T; Dokoh S; Koh T; Shimbo S; Hidaka A; Iida Y; Kasagi K; Konishi J
    Kaku Igaku; 1991 Feb; 28(2):157-61. PubMed ID: 1711131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Quantitative determination of echogenicity of diffuse inflammatory thyroid gland diseases].
    Happ J; Cordes U; Jost-Köstering S; Puhahn M
    Bildgebung; 1993 Sep; 60(3):131-4. PubMed ID: 8251734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.